دورية أكاديمية
Diagnosis of Central Precocious Puberty.
| العنوان: | Diagnosis of Central Precocious Puberty. |
|---|---|
| المؤلفون: | Bangalore Krishna K; Division of Pediatric Endocrinology and Diabetes, UPMC Childrens Hospital of Pittsburgh, 4401 Penn Avenue, Pittsburgh, PA 15224, USA. Electronic address: bangalorekrishnak2@upmc.edu., Silverman LA; Division of Pediatric Endocrinology, Goryeb Children's Hospital, Atlantic Health System, 100 Madison Avenue, Morristown, NJ 07960, USA. |
| المصدر: | Endocrinology and metabolism clinics of North America [Endocrinol Metab Clin North Am] 2024 Jun; Vol. 53 (2), pp. 217-227. Date of Electronic Publication: 2024 Mar 04. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: United States NLM ID: 8800104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-4410 (Electronic) Linking ISSN: 08898529 NLM ISO Abbreviation: Endocrinol Metab Clin North Am Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2012- : New York : Elsevier Original Publication: Philadelphia : W.B. Saunders, c1987- |
| مواضيع طبية MeSH: | Puberty, Precocious*/diagnosis , Puberty, Precocious*/blood, Child ; Child, Preschool ; Female ; Humans ; Male ; Luteinizing Hormone/blood ; Magnetic Resonance Imaging |
| مستخلص: | A thorough history and physical examination including Tanner staging and growth assessments can guide differential diagnosis and aid in the evaluation of precocious puberty. Basal luteinizing hormone levels measured using a highly sensitive assay can be helpful in diagnosing central precocious puberty (CPP). Brain MRI is indicated with males diagnosed with CPP and females under the age of 6 with CPP. As more information becomes available regarding the genetic etiologies of CPP, genetic testing may preclude the need for imaging studies and other hormonal testing, especially in familial cases. Competing Interests: Disclosure K. Bangalore Krishna has no relevant disclosures to this article. L.A. Silverman has been a consultant for Tolmar, a Data and Safety Monitoring Board member for Myovant, and with the Speaker’s Bureau for Abbvie. (Copyright © 2024 Elsevier Inc. All rights reserved.) |
| فهرسة مساهمة: | Keywords: Bone age; Brain MRI; Central precocious puberty; Gonadotropin-releasing hormone analogue; Pelvic ultrasound; Peripheral precocious puberty; Precocious puberty |
| المشرفين على المادة: | 9002-67-9 (Luteinizing Hormone) |
| تواريخ الأحداث: | Date Created: 20240427 Date Completed: 20240427 Latest Revision: 20240624 |
| رمز التحديث: | 20240625 |
| DOI: | 10.1016/j.ecl.2024.02.002 |
| PMID: | 38677865 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 1558-4410 |
|---|---|
| DOI: | 10.1016/j.ecl.2024.02.002 |